4//SEC Filing
Sveen David E. 4
Accession 0001140361-23-029893
CIK 0001038133other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:27 PM ET
Size
8.2 KB
Accession
0001140361-23-029893
Insider Transaction Report
Form 4
HESKA CORPHSKA
Sveen David E.
Director
Transactions
- Disposition to Issuer
Common Stock
2023-06-13$120.00/sh−14,285$1,714,200→ 0 total(indirect: by Bethany Creek) - Disposition to Issuer
Common Stock
2023-06-13$120.00/sh−21,653$2,598,360→ 0 total - Disposition to Issuer
Common Stock
2023-06-13$120.00/sh−7,143$857,160→ 0 total(indirect: by Lindberg Capital)
Footnotes (3)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, in exchange for cash consideration of $120.00 per share of common stock of the Issuer on the effective date of the merger.
- [F2]Represents shares held by Bethany Creek Partners, LP. Dr. Sveen is a general partner of and an investor in Bethany Creek Partners, LP.
- [F3]Represents shares held by Lindberg Capital Partners, LP. Dr. Sveen is a general partner of and an investor in Lindberg Capital Partners, LP.
Documents
Issuer
HESKA CORP
CIK 0001038133
Entity typeother
Related Parties
1- filerCIK 0001592387
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 6:27 PM ET
- Size
- 8.2 KB